AptarGroup (ATR)
NYSEMaterialsMedical - Instruments & SuppliesSnapshot 2026-11-04
$144.04-1.92%
Close 2026-11-05 · 1-day change
NYSEMaterialsMedical - Instruments & SuppliesSnapshot 2026-11-04
QuarterlyIQ Insights · ATR
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||||
| Revenues | 3,991.2 | 3,777.2 | 3,582.9 | 3,487.5 | 3,322.2 | 3,227.2 | 2,929.3 | 2,859.7 | 2,764.8 | 2,469.3 | 2,330.9 | 2,317.1 | 2,597.8 | 2,520.0 | 2,346.4 | 2,356.2 | 2,076.7 |
| Total Revenues | 3,991.2 | 3,777.2 | 3,582.9 | 3,487.5 | 3,322.2 | 3,227.2 | 2,929.3 | 2,859.7 | 2,764.8 | 2,469.3 | 2,330.9 | 2,317.1 | 2,597.8 | 2,520.0 | 2,346.4 | 2,356.2 | 2,076.7 |
| Gross Profit | — | — | — | — | — | — | 906.0 | 874.4 | 795.5 | 723.5 | 687.4 | 679.9 | 695.7 | 666.2 | 606.8 | 636.8 | — |
| Operating Expenses & Income | |||||||||||||||||
| R&D Expenses | — | 105.1 | 96.1 | 92.8 | 93.5 | 99.8 | 92.5 | 82.8 | 75.3 | 68.2 | 66.2 | 67.1 | 76.2 | 71.8 | 65.4 | 67.0 | — |
| Operating Income | 475.5 | 501.0 | 496.5 | 404.0 | 379.3 | 347.3 | 339.5 | 371.7 | 286.3 | 323.5 | 313.7 | 324.1 | 306.4 | 284.6 | 258.9 | 287.1 | 268.0 |
| Earnings from Continuing Operations | |||||||||||||||||
| Interest Expense | — | 52.7 | 43.9 | 40.4 | 40.8 | 30.3 | 33.2 | 35.5 | 32.6 | 40.6 | 35.2 | 34.6 | 21.0 | 20.5 | 19.0 | 17.3 | 14.4 |
| Interest & Investment Income | 12.9 | 11.7 | 12.1 | 4.4 | 2.7 | 3.7 | 1.0 | 4.2 | 7.1 | 5.5 | 2.6 | 5.6 | 4.8 | 3.2 | 3.0 | 5.7 | 3.2 |
| Net Interest Expenses | — | — | — | 36.0 | 38.1 | 26.6 | 32.3 | 31.3 | 25.6 | 35.1 | 32.6 | 29.0 | 16.2 | 17.3 | 16.0 | 11.6 | 11.1 |
| Asset Writedown | — | 2.2 | 0.3 | 0.3 | 0.3 | 0.4 | 0.0 | — | — | — | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | 360.7 | 491.4 | 469.8 | 374.8 | 334.7 | 321.7 | 301.2 | 342.1 | 266.0 | 294.8 | 280.5 | 294.6 | 286.3 | 264.4 | 241.4 | 274.9 | — |
| Income Tax Expense | 92.8 | 98.9 | 95.6 | 90.6 | 95.1 | 78.0 | 87.1 | 99.8 | 71.3 | 74.8 | 74.9 | 95.3 | 94.7 | 92.5 | 79.0 | 91.3 | 80.8 |
| Net Income | |||||||||||||||||
| Minority Interest | — | — | (0.4) | (0.3) | 0.3 | (0.5) | 0.1 | 0.0 | 0.0 | (0.0) | 0.0 | (0.1) | (0.0) | (0.1) | (0.2) | (0.1) | 0.1 |
| Net Income | 267.2 | 392.8 | 374.5 | 284.5 | 239.3 | 244.1 | 214.0 | 242.2 | 194.8 | 220.0 | 205.6 | 199.3 | 191.6 | 171.9 | 162.4 | 183.6 | 173.5 |
| Per Share | |||||||||||||||||
| Basic EPS | 4.21 | 5.97 | 5.65 | 4.34 | 3.66 | 3.72 | 3.32 | 3.81 | 3.12 | 3.52 | 3.27 | 3.19 | 2.95 | 2.60 | 2.45 | 2.76 | 2.58 |
| Diluted EPS | 4.17 | 5.89 | 5.53 | 4.25 | 3.59 | 3.61 | 3.21 | 3.66 | 3.00 | 3.41 | 3.17 | 3.09 | 2.85 | 2.52 | 2.38 | 2.65 | 2.48 |
| Revenue per Share | 62.22 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividend per Share | — | 1.83 | 1.72 | 1.58 | 1.52 | 1.50 | 1.44 | — | — | 1.28 | 1.22 | 1.14 | 1.09 | 1.00 | 0.88 | 0.80 | — |
| Basic Weighted Avg Shares | 63.5 | 65.7 | 66.3 | 65.6 | 65.4 | 65.7 | 64.4 | 63.6 | 62.4 | 62.4 | 62.8 | 62.6 | 65.0 | 66.1 | 66.4 | 66.6 | — |
| Diluted Weighted Avg Shares | 64.1 | 66.7 | 67.7 | 66.9 | 66.7 | 67.7 | 66.7 | 66.2 | 65.0 | 64.6 | 64.8 | 64.5 | 67.3 | 68.2 | 68.4 | 69.3 | — |
| Supplemental | |||||||||||||||||
| EBITDA | — | 788.4 | 760.3 | 652.6 | 613.0 | 582.2 | 559.8 | 566.2 | 458.0 | 476.6 | 468.5 | 463.0 | 458.6 | 434.5 | 395.9 | 421.3 | 401.0 |
| EBIT | 475.5 | 501.0 | 496.5 | 404.0 | 379.3 | 347.3 | 339.5 | 371.7 | 286.3 | 323.5 | 313.7 | 324.1 | 306.4 | 284.6 | 258.9 | 287.1 | 268.0 |
| Effective Tax Rate | 25.7% | — | — | 24.2% | 28.4% | 24.3% | 28.9% | 29.2% | 26.8% | 25.4% | 26.7% | 32.3% | 33.1% | 35.0% | 32.7% | 33.2% | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.